209 related articles for article (PubMed ID: 7576095)
21. Changes in high-dose-rate tandem and ovoid applicator positions during treatment in an unfixed brachytherapy system.
Pham HT; Chen Y; Rouby E; Lustig RA; Wallner PE
Radiology; 1998 Feb; 206(2):525-31. PubMed ID: 9457208
[TBL] [Abstract][Full Text] [Related]
22. Optimization in high dose rate brachytherapy for utero-vaginal applications.
Cetingöz R; Ataman OU; Tuncel N; Sen M; Kinay M
Radiother Oncol; 2001 Jan; 58(1):31-6. PubMed ID: 11165679
[TBL] [Abstract][Full Text] [Related]
23. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
[TBL] [Abstract][Full Text] [Related]
24. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects.
Fellner C; Pötter R; Knocke TH; Wambersie A
Radiother Oncol; 2001 Jan; 58(1):53-62. PubMed ID: 11165682
[TBL] [Abstract][Full Text] [Related]
25. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
26. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
[TBL] [Abstract][Full Text] [Related]
27. Direct reconstruction and associated uncertainties of 192Ir source dwell positions in ring applicators using gafchromic film in the treatment planning of HDR brachytherapy cervix patients.
Awunor OA; Dixon B; Walker C
Phys Med Biol; 2013 May; 58(10):3207-25. PubMed ID: 23603854
[TBL] [Abstract][Full Text] [Related]
28. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques.
Kapp KS; Stuecklschweiger GF; Kapp DS; Hackl AG
Radiother Oncol; 1992 Jul; 24(3):137-46. PubMed ID: 1410567
[TBL] [Abstract][Full Text] [Related]
29. Automated applicator digitization for high-dose-rate cervix brachytherapy using image thresholding and density-based clustering.
Deufel CL; Tian S; Yan BB; Vaishnav BD; Haddock MG; Petersen IA
Brachytherapy; 2020; 19(1):111-118. PubMed ID: 31594729
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric comparison of ring and ovoid applicators.
Tuncell N; Toy A; Demiral AN; Cetingoz R; Garipagaoglu M
J BUON; 2009; 14(3):451-5. PubMed ID: 19810138
[TBL] [Abstract][Full Text] [Related]
31. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
32. Changes in applicator position with fractionated high dose rate gynaecological brachytherapy.
Hoskin PJ; Cook M; Bouscale D; Cansdale J
Radiother Oncol; 1996 Jul; 40(1):59-62. PubMed ID: 8844889
[TBL] [Abstract][Full Text] [Related]
33. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
34. [Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].
Eich HT; Haverkamp U; Micke O; Prott FJ; Pötter R
Strahlenther Onkol; 1998 Jul; 174(7):375-80. PubMed ID: 9689959
[TBL] [Abstract][Full Text] [Related]
35. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
[TBL] [Abstract][Full Text] [Related]
36. 60 Gy isodose volumes in carcinoma of the cervix and their relation to the geometry of uterine tube and ovoids.
Jacob R; Bidmead AM; Blake PR
Br J Radiol; 1999 Feb; 72(854):168-72. PubMed ID: 10365068
[TBL] [Abstract][Full Text] [Related]
37. Significance of ovoid separation with various applications of high-dose-rate-intracavitary radiotherapy in carcinoma of uterine cervix: a study from rural centre of Maharashtra, India.
Jain VS; Singh KK; Umberkar RB; Sarje MB; Jain SM
J Cancer Res Ther; 2010; 6(2):210-4. PubMed ID: 20622370
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
[TBL] [Abstract][Full Text] [Related]
39. HDR brachytherapy applied to cervical carcinoma with moderate lateral expansion: modified principles of treatment.
Kuipers T; Hoekstra CJ; van 't Riet A; Mak AC; Vonk EJ; Elders LH; Koster K; Pop LA
Radiother Oncol; 2001 Jan; 58(1):25-30. PubMed ID: 11165678
[TBL] [Abstract][Full Text] [Related]
40. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
